Activin and Inhibin

GSK8814 is a potent, selective, and ATAD2/2B bromodomain chemical probe and inhibitor, with a binding constant pK d =8.1 and a pK i =8.9 in BROMOscan. GSK8814 binds to ATAD2 and BRD4 BD1 with pIC 50 s of 7.3 and 4.6, respectively. GSK8814 shows

GST-HG131 is a specific inbihitor of hepatitis B virus ( HBV ) surface antigen, belongs to dihydrobenzopyridooxazepine (DBP) series. GST-HG131 exhibits excellent and specific HBV antigens inhibition with EC 50 of 28.2 nM ( HBsAg ) and 16.0 nM (

GST-HG131 is a specific inbihitor of hepatitis B virus ( HBV ) surface antigen, belongs to dihydrobenzopyridooxazepine (DBP) series. GST-HG131 exhibits excellent and specific HBV antigens inhibition with EC 50 of 28.2 nM ( HBsAg ) and 16.0 nM (

GSTO-IN-2 is a glutathione S-transferase inhibitor with IC 50 s of 3.6, 16.3, and 1.4 μM for GSTA2, GSTM1, and GSTP1-1.In VitroGSTO-IN-2 is compound 3 in the reference. GSTO-IN-2 shows synergetic effect with chemotherapy drugs against two breast

GSTO-IN-2 is a glutathione S-transferase inhibitor with IC 50 s of 3.6, 16.3, and 1.4 μM for GSTA2, GSTM1, and GSTP1-1.In VitroGSTO-IN-2 is compound 3 in the reference. GSTO-IN-2 shows synergetic effect with chemotherapy drugs against two breast

GSTO-IN-2 is a glutathione S-transferase inhibitor with IC 50 s of 3.6, 16.3, and 1.4 μM for GSTA2, GSTM1, and GSTP1-1.In VitroGSTO-IN-2 is compound 3 in the reference. GSTO-IN-2 shows synergetic effect with chemotherapy drugs against two breast

Gü2602 is a potent, reversible cathepsin K (CatK) inhibitor with a K i of 0.013 nM for mature CatK (mCatK). Gü2602 suppresses the autocatalytic activation of the cathepsin K zymogenForm:SolidIC50&amp: Target:cathepsin K.

Gü2602 is a potent, reversible cathepsin K (CatK) inhibitor with a K i of 0.013 nM for mature CatK (mCatK). Gü2602 suppresses the autocatalytic activation of the cathepsin K zymogenForm:SolidIC50&amp: Target:cathepsin K.

Gü2602 is a potent, reversible cathepsin K (CatK) inhibitor with a K i of 0.013 nM for mature CatK (mCatK). Gü2602 suppresses the autocatalytic activation of the cathepsin K zymogenForm:SolidIC50&amp: Target:cathepsin K.

Gü2602 is a potent, reversible cathepsin K (CatK) inhibitor with a K i of 0.013 nM for mature CatK (mCatK). Gü2602 suppresses the autocatalytic activation of the cathepsin K zymogenForm:SolidIC50&amp: Target:cathepsin K.

Guadecitabine sodium (SGI-110 sodium) is a second-generation DNA methyltransferases ( DNMT ) inhibitor for research of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)In VitroAfter HCT116 colorectal carcinoma cells are treated for 6

Guadecitabine sodium (SGI-110 sodium) is a second-generation DNA methyltransferases ( DNMT ) inhibitor for research of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)In VitroAfter HCT116 colorectal carcinoma cells are treated for 6